Both in Pharmaceuticals
Q32 Bio vs USANA Health Sciences
Over the past year QTTB returned +278.5% and USNA returned −30.3%; their daily moves had a correlation of -0.02.
QTTB +278.5% USNA −30.3%Growth of $1, one year, split-adjusted
| Metric | QTTB | USNA |
|---|---|---|
| Price | $8.97 | $14.33 |
| Market cap | $267.0M | $264.8M |
| Today | +2.40% | −3.63% |
| 1 month | +10.6% | −3.4% |
| 6 months | +64.0% | −28.4% |
| Year to date | +170.2% | −27.0% |
| 1 year | +249.0% | −32.6% |
| Revenue growth (YoY) | — | −5.3% |
| Gross margin | — | 78.3% |
| Net margin | — | −9.6% |
| P/E (TTM) | 7.9× | — |
| Price / sales | 5.0× | 0.3× |
| Net cash | $106.3M | $168.6M |
| Dividend yield | — | — |
| Volatility (60d) | 63.1% | 34.7% |
| Short % of float | 32.6% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).